Project
|
CAS
|
Indications
|
State
|
---|---|---|---|
Eltrombopag Olamine
Eltrombopag Olamine
|
496775-62-3 |
Treatment of aplastic anemia Treat thrombocytopenia Treating idiopathic thrombocytopenic purpura Treatment of chronic hepatitis C |
FDA Record No.: MF037269 |
Isaconazole sulfate
Isavuconazonium Sulfate
|
946075-13-4 |
Treat fungal infections |
CDE Registration No.: Y20230000865 FDA Record No.: MF039193 |
Crisaborole
Crisaborole
|
906673-24-3 |
Treat atopic dermatitis |
CDE Registration No.: Y20230000644 |
Elagolix Sodium
Elagolix Sodium
|
832720-36-2 |
Treatment of endometriosis |
CDE Registration No.: Y20220000676 |
Phloroglucinol
Phloroglucinol
|
108-73-6 |
Alleviate acute spasmodic pain |
CDE Registration No.: Y20220000230 |
Intermediate name
|
CAS.No
|
structural formula
|
Intermediate name
|
CAS.No
|
structural formula
|
---|---|---|---|---|---|
3-噻吩羧酸, 5-(4-氨基苯基)-2-[[(2,6-二氟苯基)甲基](乙氧羰基)氨基]-4-[(二甲氨基)甲基]-乙酯盐酸盐
|
2768834-98-4
|
|
2-[(2,6-二氟苄基)乙氧基羰基氨基]-4-甲基-5-(4-硝基苯基)噻吩-3-羧酸乙酯
|
308831-94-9
|
|
2-[(2 ,6-二氟苄基)乙氧基羰基氨基]-4-((二甲基氨基)甲基)-5-(4-硝基苯基)噻吩-3-甲酸乙酯
|
1589503-97-8
|
|
3-氨基-6-甲氧基哒嗪
|
7252-84-8
|
|
2-((2,6-二氟苄基)(乙氧基羰基)氨基)-4-((二甲基氨基)甲基)-5-(4-硝基苯基)噻吩-3-羧酸
|
1589503-95-6
|
|
Disclaimer: you confirm that these products cannot be supplied to countries where their use and / or commercialization may conflict with the existing intellectual property rights of third parties.